Forced cytochrome B gene mutation expression induces mitochondrial proliferation and prevents apoptosis in human uroepithelial SV-HUC-1 cells

International Journal of Cancer

Volumn 125, Issue 12, 2009, Pages 2829-2835

  Dasgupta, Santanu ^a   Hoque, Mohammad Obaidul ^a   Upadhyay, Sunil ^a   Sidransky, David ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Apoptosis; Cytochrome B mutation; Mitochondria; mtDNA content

Indexed keywords

CYCLOOXYGENASE 1; CYTOCHROME B; CYTOCHROME C; LAMIN B; LAMIN B1; MITOCHONDRIAL DNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PROTEIN BAX; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; CYTOPLASM; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; MITOCHONDRION; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN SECRETION;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BLOTTING, WESTERN; CELL LINE, TRANSFORMED; CELL PROLIFERATION; CELLS, CULTURED; CYTOCHROMES B; CYTOPLASM; DNA, MITOCHONDRIAL; ENZYME INHIBITORS; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN PEROXIDE; MITOCHONDRIA; MUTATION; PROTO-ONCOGENE PROTEINS C-BCL-2; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SIMIAN VIRUS 40; STAUROSPORINE; TRANSFECTION; UROTHELIUM;

EID: 72449125363     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24701     Document Type: Article

References (21)

1. Petros JA, Baumann AK, Ruiz-Pesini E, Amin MB, Sun CQ, Hall J, Lim S, Issa MM, Flanders WD, Hosseini SH, Marshall FF, Wallace DC. mtDNA mutations increase tumorigenicity in prostate cancer. Proc Natl Acad Sci USA 2005;102:719-724 (Pubitemid 40282732)
2. Blakely EL, Mitchell AL, Fisher N, Meunier B, Nijtmans LG, Schaefer AM, Jackson MJ, Turnbull DM, Taylor RW. A mitochondrial cytochrome b mutation causing severe respiratory chain enzyme deficiency in human and yeast. FEBS J 2005;272:3583-3592 (Pubitemid 41021171)
3. MITOMAP. 2005. Available at:http://www.mitomap.org
4. Wallace DC. A mitochondrial paradigm of metabolic and degenerative disease, aging, and cancer: a dawn for evolutionary medicine. Annu Rev Genet 2005;39:359-407.
5. Polyak K, Li Y, Zhu H, Lengauer C, Willson JK, Markowitz SD, Trush MA, Kinzler KW, Vogelstein B. Somatic mutations of the mitochondrial genome in human colorectal tumors. Nat Genet 1998;20:291-293 (Pubitemid 28507677)
6. Fliss MS, Usadel H, Caballero OL, Wu L, Buta MR, Eleff SM, Jen J, Sidransky D. Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000;287:2017-2019 (Pubitemid 30158678)
7. Liu VWS, Shi HH, Cheung ANY, Chiu PM, Leung TW, Nagley P, Wong LC, Ngan HYS. High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res 2001;61:5998-6001. (Pubitemid 32762527)
8. Parrella P, Xiao Y, Fliss M, Sanchez-Cespedes M, Mazzarelli P, Rinaldi M, Nicol T, Gabrielson E, Cuomo C, Cohen D, Pandit S, Spencer M, et al. Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res 2001;61:7623-7636 (Pubitemid 32995057)
9. Máximo V, Soares P, Lima J, Cameselle-Teijeiro J, Sobrinho-Simões M. Mitochondrial DNA somatic mutations (point mutations and large deletion) and mitochondrial DNA variants in human thyroid pathology. Am J Pathol 2002;160:1857-1865
10. Dasgupta S, Hoque MO, Upadhyay S, Sidransky D. Mitochondrial cytochrome B gene mutation promotes tumor growth in bladder cancer. Cancer Res 2008;38:700-706 (Pubitemid 351206745)
11. Dasgupta S, Bhattacharya-Chatterjee M, O'Malley BW, Jr, Chatterjee SK. Tumor metastasis in an orthotopic murine model of head and neck cancer: possible role of TGF-Beta 1 secreted by the tumor cells. J Cell Biochem 2006;97:1036-1051
12. Berliner JA. Formation of enriched mitochondria in a liver cell line. J Cell Biol 1975;64:711-716
13. Mambo E, Chatterjee A, Xing M, Tallini G, Haugen BR, Yeung SC, Sukumar S, Sidransky D. Tumor-specific changes in mtDNA content in human cancer. Int J Cancer 2005;116:920-924 (Pubitemid 41209199)
14. Saitoh Y, Ouchida R, Miwa N. BCl-2 prevents hypoxia/reoxygenation-induced cell death through suppressed generation of reactive oxygen species and upregulation of BCL-2 protein. J Cell Biochem 2003;90:914-924 (Pubitemid 37467107)
15. Hickman ES, Helin K. The regulation of APAF1 expression during development and tumorigenesis. Apoptosis 2002;7:167-171 (Pubitemid 34273132)
16. Eliseev R, Rosier R. The role of NFκB in regulation of mitochondrial structure and function in cancer cells. Proc Am Assoc Cancer Res 2007 (Abstract number 4487).
17. Tsujimoto Y, Shimizu S. VDAC regulation by the Bcl-2 family of proteins. Cell Death Differ 2000;7:1174-1181 (Pubitemid 32042224)
18. Alirol E, Martinou JC. Mitochondria and cancer: is there a morphological connection? Oncogene 2006;25:4706-4716
19. Holleman A, den Boer ML, Kazemier KM, Beverloo HB, von Bergh AR, Janka-Schaub GE, Pieters R. Decreased PARP and pro-caspase- 2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia. Blood 2005;106:1817-1823 (Pubitemid 41208599)
20. Prokocimer M, Margalit A, Gruenbaum Y. The nuclear lamina and its proposed role in tumorigenesis: projection on the hematologic malignancies and future targeted therapy. J Struct Biol 2006;155:351-360 (Pubitemid 44376369)
21. Jiang WW, Rosenbaum E, Mambo E, Zahurak M, Masayesva B, Carvalho AL, Zhou S, Westra WH, Alberg AJ, Sidransky D, Koch W, Califano JA. Decreased mitochondrial DNA content in posttreatment salivary rinses from head and neck cancer patients. Clin Cancer Res 2006;12:1564-1569